U.S. Markets closed

Should You Keep Your Portfolio Healthy with Biotech ETFs?

Sanghamitra Saha

The biotech sector is going through the roof right now with SPDR S&P Biotech ETF XBI adding over 9% in a month (as of Sep 11, 2017). Plenty of factors are powering the sector. Among these, breakthrough U.S. Food and Drug Administration (FDA) approvals, success in the immune-oncology field, and mergers and acquisitions are at the forefront.

Biotech stock Vertex Pharmaceuticals VRTX received a new FDA approval for cystic fibrosis drug, Kalydeco. In early September, FDA approved “Novartis AG' breakthrough gene transfer treatment, Kymriah (tisagenlecleucel) suspension for the treatment of patients up to 25 years of age with B-cell precursor acute lymphoblastic leukemia that is refractory or in second or later relapse,” as per the source.

Investors should note that CAR-T is a fresh immunocellular therapy and many companies are eyeing it. In fact, Gilead Sciences GILD announced the buyout of Kite Pharma KITE for $11.9 billion in late August (read: Biotech ETFs Soar on Gilead-Kite Deal). Kite Pharma is expected to receive approval for its CAR-T therapy axicabtagene ciloleucel (axi-cel) shortly. With this acquisition, Gilead will step into the new arena of oncology treatment, known as CAR-T, which targets the body’s own immune system to fight tumors.

Two months ago, Clovis Oncology CLVS shares also skyrocketed following the company’s positive cancer drug data. The company then said that clinical trial data on its ovarian cancer drug treatment indicated that it may substantially help more patients than expected (read: 4 Stocks & ETFs to Buy on Clovis' Positive Drug Data).

If this was not enough, Teva Pharmaceutical TEVA shares surged over 19% on Sep 11 as it appointed a former Novo Nordisk (NVO) as CEO. The new recruitment followed Teva’s last full-time CEO’s seven-month term and resignation amid a bribery scandal.

Compelling Valuation

Biotech stocks were the most hurt among the S&P 500 members last year. This has probably made the space cheap and helped it to be back with a bang. Biotech ETF XBI added about 17.7% in the last three months (as of Sep 11, 2017) while SPDR S&P 500 ETF SPY was up 2.9%. The fund XBI has a relative strength index of 66.95. This means that the fund is yet to enter the overbought territory.

Also, fears over price gouging are ebbing substantially in the Trump administration. In a nutshell, the space is riding on research and development and may log more returns ahead.

ETFs to Tap

Below we highlight a few biotech ETFs that can benefit investors with solid gains (see all Health Care ETFs here).

Direxion Daily S&P Biotech Bull 3X LABU

Ultrapro Nasdaq Biotechnology Proshares UBIO

ProShares Ultra Nasdaq Biotechnology BIB

iShare Nasdaq Biotech ETF IBB

Bioshares Biotech Clinical Trial BBC

VanEck Vectors Biotech ETF BBH

Bioshares Biotech Products BBP    

Loncar Cancer Immunotherapy ETF CNCR    

ALPS Medical Breakthroughs ETF SBIO

Want key ETF info delivered straight to your inbox?

Zacks’ free Fund Newsletter will brief you on top news and analysis, as well as top-performing ETFs, each week. Get it free >>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
SPDR-SP 500 TR (SPY): ETF Research Reports
 
ISHARES NDQ BIO (IBB): ETF Research Reports
 
PRO-ULT NDQ BIO (BIB): ETF Research Reports
 
LONCAR CANCER (CNCR): ETF Research Reports
 
DIRX-D SP BBULL (LABU): ETF Research Reports
 
PRO-ULT ND BI (UBIO): ETF Research Reports
 
BIOSH-BIO CLNCL (BBC): ETF Research Reports
 
BIOSH-BIO PRD (BBP): ETF Research Reports
 
SPDR-SP BIOTECH (XBI): ETF Research Reports
 
VANECK-BIOTECH (BBH): ETF Research Reports
 
ALPS-MED BRKTH (SBIO): ETF Research Reports
 
Vertex Pharmaceuticals Incorporated (VRTX) : Free Stock Analysis Report
 
Gilead Sciences, Inc. (GILD) : Free Stock Analysis Report
 
Clovis Oncology, Inc. (CLVS) : Free Stock Analysis Report
 
Kellogg Company (K) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research
 
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

  • French Olympic Ice Dancer Suffers Serious Wardrobe Malfunction
    Sports
    Time

    French Olympic Ice Dancer Suffers Serious Wardrobe Malfunction

    French ice dancers Guillaume Cizeron and Gabriella Papadakis took second place in Monday’s short program despite a wardrobe malfunction. During the duo’s performance, Papadakis’ costume appeared to unhook from around her neck, exposing her left breast for part of the routine. The malfunction did seem to impair their final score of 81.93, but not enough to stop them from finishing second behind Scott Moir and Tessa Virtue of Canada, who scored 83.67.

  • Bitcoin Gives up $11,000 as the Market Prepares for the Litecoin Fork
    Business
    FX Empire

    Bitcoin Gives up $11,000 as the Market Prepares for the Litecoin Fork

    Bitcoin was amongst the top performers on Saturday, gaining 9.17% to end the day at $11,139.03, just shy of an intraday high $11,159.81. This week, in spite of continued uncertainty, investors have returned to the market, though this morning’s reversal has seen the total cryptomarket cap fall to $493.47bn, with Bitcoin’s market cap down to $181.24bn. One area of focus later today will be Litecoin’s hard fork that is expected to result in the distribution of Litecoin Cash coins to Litecoin holders.

  • 4 Reasons Why a 401(k) Is Better Than a Pension
    Business
    Motley Fool

    4 Reasons Why a 401(k) Is Better Than a Pension

    Pensions are a dying perk: Just 4% of workers in the private sector enjoy this particular retirement benefit compared to about 60% in the early 1980s. Many employers instead offer access to a 401(k) plan, leaving it up to workers to save for their own retirement, though perhaps with a bit of help in the form of matching contributions. Just consider the following facts about your 401(k).

  • Business
    MarketWatch

    Should I sell my $565,000 duplex and invest the money — or continue to collect rent?

    The main question is whether I would get a better return by selling the duplex and investing the money or by keeping the property and collecting rent. What if the rental is vacant for a period of time?

  • What's Next for Figure Skating at the 2018 Winter Olympics
    Sports
    Time

    What's Next for Figure Skating at the 2018 Winter Olympics

    Adam Rippon was one of the first openly gay male athletes to compete for the U.S. at the Winter Olympics. Nathan Chen, a medal favorite who missed his chance on the podium this time around, still landed a record-breaking six quads in his final performance. Several members of Team USA’s figure skating team at the Winter Olympics have made history at the Games this year, and fans have several more chances to see the skaters in action before they return to the U.S.

  • Qualcomm is moving to decide how to price NXP deal to lure in enough shareholders
    Business
    CNBC.com

    Qualcomm is moving to decide how to price NXP deal to lure in enough shareholders

    Qualcomm and its advisors have been working to reassert control over the company's deal to acquire NXP Semiconductors this weekend, by trying to figure out what price will be enough to garner the 80 percent of shares needed to close the deal, sources tell CNBC. On Friday, Qualcomm's advisors at Goldman Sachs began contacting large holders of NXP to ascertain at what price those holders would be willing to sign voting agreements stipulating their support for a deal, according to people familiar with the conversations. While no specific price was offered, Qualcomm's advisors were said to have broached "the low $120's" as a possibility for a deal. This is Qualcomm's first effort in months to see what price large holders of NXP Semi would be willing to accept in order for Qualcomm to close the all cash deal, which is worth more than $40 billion.

  • 401(k) Accounts Hit a New Record Level -- Is Yours Keeping Up?
    Business
    Motley Fool

    401(k) Accounts Hit a New Record Level -- Is Yours Keeping Up?

    Most Americans are not where they should be in terms of savings for retirement. The situation is actually dire for many of them. Still, there's some good news: The average balance of Americans' 401(k) accounts hit a record high at the end of 2017. That

  • Oil hits two-week high on share market recovery, Middle East tensions
    Business
    Reuters

    Oil hits two-week high on share market recovery, Middle East tensions

    Oil prices hit their highest level in nearly two weeks on Monday, lifted by a global equity market recovery and tensions in the Middle East, although concerns of rising U.S. production tempered gains. Brent crude (LCOc1) was up 34 cents at $65.18 a barrel at 1356 GMT, after rising to an 11-day high of $65.45 a barrel earlier in the session. "Benign stock markets are providing ... as are geopolitical tensions in the Middle East," Commerzbank said in a note.

  • The iPhone X May Be Here to Stay
    Business
    Motley Fool

    The iPhone X May Be Here to Stay

    The Apple (NASDAQ: AAPL) supply chain has been rife with rumors that the iPhone maker will end production of its flagship device this year. Noted Apple analyst Ming-Chi Kuo of KGI Securities believes that weak demand for the iPhone X is forcing the company to reduce component orders. Kuo says production of the iPhone X will be halted later this year when the new 2018 models go into production.

  • Paul Ryan: Deficit increase is due to entitlement spending
    Politics
    Fox Business Videos

    Paul Ryan: Deficit increase is due to entitlement spending

    House Speaker Ryan talks need to reform health care, breaks down the budget deal that was passed on 'Sunday Morning Futures.'

  • This Is Warren Buffett’s Top Equity Holding, Surpassing Wells Fargo
    Business
    Fortune

    This Is Warren Buffett’s Top Equity Holding, Surpassing Wells Fargo

    Warren Buffett's Inc. has taken a real shine to Inc. Berkshire boosted its holding of the iPhone maker to $28 billion at year-end, surpassing its stake in & Co., which was worth $27.8 billion on Dec. 31. Apple has continued to rally this year, increasing the value of Berkshire's stake to $28.6 billion based on Thursday's closing price.

  • Jeff Sessions talks immigration reform and the Mueller probe
    Politics
    Fox Business Videos

    Jeff Sessions talks immigration reform and the Mueller probe

    Sessions speaks out about the need to eliminate 'lawlessness' in the immigration system and discusses the Russia investigation on 'Sunday Morning Futures.'

  • Why General Motors Could Be Leaving Korea for Good
    Business
    Motley Fool

    Why General Motors Could Be Leaving Korea for Good

    In recent years, General Motors (NYSE: GM) has posted consistently strong profits in its two largest markets: North America and China. It's seeming increasingly likely that GM will ultimately have to end its manufacturing operations there to achieve this goal. Management first publicly raised the need for restructuring at GM Korea during General Motors' fourth-quarter earnings call earlier this month.

  • David Tepper's Appaloosa Portfolio Jumped Nearly 50%: 13F
    Business
    Investopedia

    David Tepper's Appaloosa Portfolio Jumped Nearly 50%: 13F

    Billionaire David Tepper, the head of Appaloosa Management, recently filed his quarterly 13F report. According to the SEC filings, Appaloosa's value increase by almost 50% in the last quarter of 2017. As of the start of 2018, Appaloosa Management's largest holdings were Micron Technology Inc. (MU), Facebook Inc. (FB), and Powershares QQQ Trust (QQQ). $10.5 Billion Portfolio Stocks in Appaloosa's portfolio which were represented on the 13F filings totaled $10.5 billion as of December 31, 2017. The list value for those stocks was up an astonishing 47.5% as compared with the previous quarter, according to Value Walk. By comparison, the S&P 500 was up just over 6% over the same period. At a time

  • Business
    Benzinga

    Barron's Picks And Pans: GE, Under Armour, Lam Research And More

    This weekend's Barron's cover story offers a look at the prospects for a troubled industrial giant. Other featured articles offer four stock picks for an aging bull market and the prospects for real estate investment trusts as interest rates rise. "General Electric's Dim Prospects" by Andrew Bary examines why the slide in the shares of troubled industrial giant General Electric Company (NYSE: GE) has attracted bargain hunters.

  • Iran Fails To Comply With OPEC Deal
    Business
    Oilprice.com

    Iran Fails To Comply With OPEC Deal

    The OPEC Monthly Oil Market Report is out production data for January 2018. All data, unless otherwise noted, is through January 2018 and is in thousand barrels per day. OPEC crude only production has held steady for three months.

  • Business
    MarketWatch

    This is how much credit-card debt makes you undatable

    More than 77% of people consider credit-card debt unattractive, according to a survey released Monday by personal-finance site Finder.com. On average, people say $11,525 in credit-card debt is enough of a red flag to swipe left or walk away. Payday loans, which can have astronomical interest rates as high as 400%, are the second most unacceptable forms of debt for daters.

  • NVIDIA’s Earnings Report Reveals a Worrying Problem
    Business
    Motley Fool

    NVIDIA’s Earnings Report Reveals a Worrying Problem

    The NVIDIA (NASDAQ: NVDA) juggernaut continues to outperform as the graphics card specialist topped Wall Street expectations once again with a terrific showing in the fourth quarter of fiscal 2018. The company reported a steep rise in its revenue and earnings, thanks mainly to a massive year-over-year jump in its data center and gaming businesses. What's more, NVIDIA expects stronger growth in the current quarter, forecasting a 50% year-over-year increase in revenue, while net income could jump close to 82%.

  • Gilead wins reversal of $2.54 billion hepatitis C drug patent verdict
    Business
    Reuters

    Gilead wins reversal of $2.54 billion hepatitis C drug patent verdict

    A federal judge in Delaware has overturned a jury's verdict requiring Gilead Sciences Inc to pay a record $2.54 billion because its hepatitis C drugs Sovaldi and Harvoni infringed a patent held by rival Merck & Co Inc. The verdict had been the largest ever in a U.S. patent case but U.S. District Judge Leonard Stark in Wilmington, Delaware, on Friday ruled Merck's patent was invalid. Gilead in a statement on Saturday said it always believed the patent was invalid and was pleased the judge confirmed that opinion. The December 2016 verdict followed a trial in which jurors found that Merck's patent on hepatitis C treatments, which it acquired in 2014 when it bought Idenix Pharmaceuticals, was valid.

  • Walmart, Home Depot — What you need to know for the week ahead
    Business
    Yahoo Finance

    Walmart, Home Depot — What you need to know for the week ahead

    The tech-heavy Nasdaq, which was the only losing among the major averages on Friday, paced gains for the week, rising 5%. Fourth quarter earnings season is winding down, but a couple of premier reports are expected on Tuesday morning as both Walmart (WMT) and Home Depot (HD) will report results. Walmart earnings on Tuesday morning will give investors a read on the U.S. consumer.

  • Amerisource shares jump on Walgreens buyout report
    Finance
    Associated Press

    Amerisource shares jump on Walgreens buyout report

    Shares of AmerisourceBergen soared Tuesday on reports that Walgreens is pursuing a complete takeover of the huge drug distributor. The Wall Street Journal reported late Monday that Walgreens Boots Alliance Inc. reached out to AmerisourceBergen Corp. about a potential deal several weeks ago. Walgreens already owns about 26 percent of the company, according to data provider FactSet.

  • Here's How to Retire Early
    Business
    Motley Fool

    Here's How to Retire Early

    Are you dreaming of an early retirement? Who wouldn't want an opportunity to enjoy that flexibility at the earliest possible age? Of course, when we think about early retirement, we tend to picture those folks who strike it rich with a killer investment or make millions on a brilliant Shark Tank-style idea.

  • Delta Air Lines Wants the Boeing "797" ASAP: Here's Why
    Business
    Motley Fool

    Delta Air Lines Wants the Boeing "797" ASAP: Here's Why

    Last year, Boeing (NYSE: BA) strained its relationship with U.S. airline giant Delta Air Lines (NYSE: DAL) by attempting to have big tariffs imposed on Delta's purchase of CSeries jets from Bombardier. Many pundits saw Boeing's trade complaint as a risky move that could alienate a key customer -- especially after Delta ordered the Airbus (NASDAQOTH: EADSY) A321neo last December instead of Boeing's 737 MAX 10. Delta isn't going to make bad business decisions just to punish Boeing.

  • Mueller Deflates President Trump's Claim That Russia Meddling Was Hoax
    Politics
    Fortune

    Mueller Deflates President Trump's Claim That Russia Meddling Was Hoax

    Donald Trump has insisted for more than a year that Russians didn’t try to get him elected. Special Counsel Robert Mueller put an end to those claims on Friday, declaring definitively that they did. A federal grand jury indicted 13 Russian nationals and a so-called “troll farm” in St. Petersburg on Friday for a broad campaign to sway the 2016 election in Trump’s favor.

  • What to Do With Your 401(k) When the Market Crashes
    Business
    Motley Fool

    What to Do With Your 401(k) When the Market Crashes

    Market crashes are scary. After a long bull market in which the S&P repeatedly hit new record highs, it's hard to see the retirement savings that you've worked for years to save in a 401(k) take a severe hit when the good times come to an end. The key to handling volatility is to be smart about risk management, anticipating worst-case scenarios and adjusting your strategy to allow for them.